![]() The Company’s most targeted sectors include life science (46) and medical products (46). Meridian Bioscience has acquired in 6 different US states, and 4 countries. The company also had made a name for itself by testing for E. Meridian Bioscience’s largest acquisition to date was in 2019, when it acquired GenePOC - State-of-the-Art Molecular Diagnostics Platform for 120M. The company has a market cap of 1.40 billion, a price-to-earnings ratio of 32. According to the Centers for Disease Control and Prevention, CMV is the most common cause of infant brain damage and affects one of every 200 infants. Shares of VIVO stock opened at 31.90 on Thursday. Apply to any positions you believe you are a fit. Please browse all of our available job and career opportunities. Welcome to the Careers Center for Meridian Bioscience. Some of Meridian's other tests include Alethia, which tests for congenital cytomegalovirus (CMV). I consent to allow Meridian to use cookies and to allow sharing information about my use of this website with Meridian’s social media, advertising, and analytics partners. That's a positive sign for Meridian, whose primary business is making test kits for infectious respiratory diseases, gastrointestinal diseases, and elevated blood lead levels, according to its annual report. Meridian Bioscience Inc is a medical diagnostics company responsible for developing and manufacturing a broad range of innovative diagnostic kits using a. ![]() ![]() The Cincinnati-based company saw a 5.8% revenue dip last year, but it was the third consecutive year in which it improved both its net income and earnings per share.Īs healthcare costs have soared, the demand for more diagnostic tests has increased. Meridian was already on a rise before the pandemic ![]() While sales in its diagnostics and life sciences segments grew, the biggest jump was in molecular reagents, which brought in $11.5 million, a 114% rise year over year. Meridian reported $57.3 million in revenue for the quarter, which it said was up 14% compared with the same quarter in 2019. Meridian saw fourth quarter profits in 2020 skyrocket 26, WVXU reported, with 253 million in sales for 2020 and more than 300 million in 2021. MERIDIAN BIOSCIENCE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |